Marrone Bio Innovations Grandevo bioinsecticide receives completeness determination in Europe

Marrone Bio Innovations (MBI), a provider of bio-based pest management and plant health products for the agriculture, turf and ornamental and water treatment markets, said Monday that its Grandevo bioinsecticide has received a completeness determination from the European Commission.

Grandevo is now cleared to begin evaluation for Annex 1 listing and commercialization in the European Union, MBI said.
 
Grandevo is an advanced broad-spectrum bioinsecticide that offers protection against chewing and sucking insects and mites including thrips, whiteflies, Asian citrus psyllid, armyworms and other pest caterpillars, mites, lygus bug, mealybugs and soil-inhabiting pests, MBI said.

A policy decision by the European Commission, the European Food Safety Authority and a Working Group of EU Member States has allowed Grandevo to be evaluated as a microbial pesticide. Until this recent EU decision, only pesticides containing live microbes could be evaluated under EU regulation.

Grandevo is being assessed under the Netherlands government's "Green Deal" Initiative, which has been created to speed up the sustainability of plant protection products (PPPs) in agriculture and horticulture by facilitating the authorization of green PPPs with a low risk for humans, animals and the environment.

MBI believes that efficacy trials recently completed in Europe will be used to support the potential uses of Grandevo for the control of whitefly and thrips in diverse crops.

Organizations in this story

Marrone Bio Innovations, Inc 1540 Drew Ave Davis, CA 95618

Get notified the next time we write about Marrone Bio Innovations, Inc!